142 related articles for article (PubMed ID: 26219558)
1. Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
[TBL] [Abstract][Full Text] [Related]
2. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
3. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
4. Role of the transcription factor Bcl11b in development and lymphomagenesis.
Kominami R
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
[TBL] [Abstract][Full Text] [Related]
6. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
[TBL] [Abstract][Full Text] [Related]
7. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.
Kamimura K; Ohi H; Kubota T; Okazuka K; Yoshikai Y; Wakabayashi Y; Aoyagi Y; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2007 Apr; 355(2):538-42. PubMed ID: 17306224
[TBL] [Abstract][Full Text] [Related]
9. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
[TBL] [Abstract][Full Text] [Related]
11. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
[TBL] [Abstract][Full Text] [Related]
12. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
14. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
15. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.
Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
[TBL] [Abstract][Full Text] [Related]
16. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
[TBL] [Abstract][Full Text] [Related]
18. Generation of Inducible
Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.
Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109
[TBL] [Abstract][Full Text] [Related]
20. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]